Cooperation between DMP1 loss and cyclin D1 overexpression in breast cancer

American Journal of Pathology

Volumn 183, Issue 4, 2013, Pages 1339-1350

  Zhu, Sinan ^a   Mott, Ryan T ^a   Fry, Elizabeth A ^a   Taneja, Pankaj ^a,b   Kulik, George ^a   Sui, Guangchao ^a   Inoue, Kazushi ^a,b,c  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

^b INSTITUTE OF NUCLEAR MEDICINE AND ALLIED SCIENCES   (India)

^c Institute of Nuclear Medicine and Allied Science ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN D1; DENTIN MATRIX PROTEIN 1;

ANIMAL CELL; ANIMAL CELL CULTURE; ANIMAL EXPERIMENT; APOPTOSIS; ARTICLE; BREAST CANCER; CARCINOGENESIS; CELL CYCLE; CHROMATIN IMMUNOPRECIPITATION; GENE ACTIVATION; GENE LOSS; GENE OVEREXPRESSION; IN VITRO STUDY; MOUSE; MUTAGENESIS; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; TUMOR SUPPRESSOR GENE;

ANIMALS; APOPTOSIS; BREAST NEOPLASMS; CARCINOGENESIS; CYCLIN D1; CYCLIN-DEPENDENT KINASE INHIBITOR P16; FEMALE; FIBROBLASTS; G2 PHASE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MAMMARY NEOPLASMS, EXPERIMENTAL; MAMMARY TUMOR VIRUS, MOUSE; MICE; MICE, TRANSGENIC; MITOSIS; MUTATION; NEOPLASM METASTASIS; PROMOTER REGIONS, GENETIC; TRANSCRIPTION FACTORS;

EID: 84884542471     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.1016/j.ajpath.2013.06.027     Document Type: Article

References (38)

1. R.L. Sutherland, and E.A. Musgrove Cyclins and breast cancer J Mammary Gland Biol 9 2004 95 104
2. A. Arnold, and A. Papanikolaou Cyclin D1 in breast cancer pathogenesis J Clin Oncol 23 2005 4215 4224
3. M.F. Fu, C.G. Wang, Z.P. Li, T. Sakamaki, and R.G. Pestell Minireview: cyclin D1: normal and abnormal functions Endocrinol 145 2004 5439 5447
4. J. Lamb, S. Ramaswamy, H.L. Ford, B. Contreras, R.V. Martinez, F.S. Kittrell, C.A. Zahnow, N. Patterson, T.R. Golub, and M.E. Ewen A mechanism of cyclin D1 action encoded in the patterns of gene expression in human cancer Cell 114 2003 323 334
5. E.A. Musgrove, C.E. Caldon, J. Barraclough, A. Stone, and R.L. Sutherland Cyclin D as a therapeutic target in cancer Nat Rev Cancer 11 2011 558 572
6. R.M. Zwijsen, E. Wientjens, R. Klompmaker, J. van der Sman, R. Bernards, and R.J. Michalides CDK-independent activation of estrogen receptor by cyclin D1 Cell 88 1997 405 415
7. K.E. Knudsen, W.K. Cavenee, and K.C. Arden D-type cyclins complex with the androgen receptor and inhibit its transcriptional transactivation ability Cancer Res 59 1999 2297 2301
8. S. Horstmann, S. Ferrari, and K.H. Klempnauer Regulation of B-Myb activity by cyclin D1 Oncogene 19 2000 298 306
9. M.F. Fu, C.G. Wang, M. Rao, X.F. Wu, T. Bouras, X.P. Zhang, Z.P. Li, X.M. Jiao, J.G. Yang, A.P. Li, N.D. Perkins, B. Thimmapaya, A.L. Kung, A. Munoz, A. Giordano, M.P. Lisanti, and R.G. Pestell Cyclin D1 represses p300 transactivation through a cyclin-dependent kinase-independent mechanism J Biol Chem 280 2005 29728 29742
10. M.F. Rubio, P.N. Fernandez, C.V. Alvarado, L.C. Panelo, M.R. Grecco, G.P. Colo, G.A. Martínez-Noel, S.M. Micenmacher, and M.A. Costas Cyclin D1 is a NF-κB corepressor Biochim Biophys Acta 1823 2012 1119 1131
11. F. Bienvenu, S. Jirawatnotai, J.E. Elias, C.A. Meyer, K. Mizeracka, A. Marson, G.M. Frampton, M.F. Cole, D.T. Odom, J. Odajima, Y. Geng, A. Zagozdzon, M. Jecrois, R.A. Young, X.S. Liu, C.L. Cepko, S.P. Gygi, and P. Sicinski Transcriptional role of cyclin D1 in development revealed by a genetic-proteomic screen Nature 463 2010 374 378
12. K. Inoue, R. Wen, J.E. Rehg, M. Adachi, J.L. Cleveland, M.F. Roussel, and C.J. Sherr Disruption of the ARF transcriptional activator DMP1 facilitates cell immortalization, Ras transformation, and tumorigenesis Genes Dev 14 2000 1797 1809
13. K. Inoue, F. Zindy, D.H. Randle, J.E. Rehg, and C.J. Sherr Dmp1 is haplo-insufficient for tumor suppression and modifies the frequencies of Arf and p53 mutations in Myc-induced lymphomas Gene Dev 15 2001 2934 2939
14. K. Inoue, M.F. Roussel, and C.J. Sherr Induction of ARF tumor suppressor gene expression and cell cycle arrest by transcription factor DMP1 Proc Natl Acad Sci U S A 96 1999 3993 3998
15. D. Maglic, S. Zhu, E.A. Fry, P. Taneja, F. Kai, R.D. Kendig, T. Sugiyama, L.D. Miller, M.C. Willingham, and K. Inoue Prognostic value of the hDMP1-ARF-Hdm2-p53 pathway in breast cancer Oncogene 2012 [Epub ahead of press]
16. A. Mallakin, T. Sugiyama, P. Taneja, L.A. Matise, D.P. Frazier, M. Choudhary, G.A. Hawkins, R.B. D'Agostino, M.C. Willingham, and K. Inoue Mutually exclusive inactivation of DMP1 and ARF/p53 in lung cancer Cancer Cell 12 2007 381 394
17. P. Taneja, D. Maglic, F. Kai, T. Sugiyama, R.D. Kendig, D.P. Frazier, M.C. Willingham, and K. Inoue Critical roles of DMP1 in human epidermal growth factor receptor 2/neu-Arf-p53 signaling and breast cancer development Cancer Res 70 2010 9084 9094
18. K. Inoue, C.J. Sherr, and L.H. Shapiro Regulation of the CD13/aminopeptidase N gene by DMP1, a transcription factor antagonized by D-type cyclins J Biol Chem 273 1998 29188 29194
19. R. Sreeramaneni, A. Chaudhry, M. McMahon, C.J. Sherr, and K. Inoue Ras-Raf-Arf signaling critically depends on the Dmp1 transcription factor Mol Cell Biol 25 2005 220 232
20. J.A. Diehl, F. Zindy, and C.J. Sherr Inhibition of cyclin D1 phosphorylation on threonine-286 prevents its rapid degradation via the ubiquitin-proteasome pathway Genes Dev 11 1997 957 972
21. K. Inoue, and C.J. Sherr Gene expression and cell cycle arrest mediated by transcription factor DMP1 is antagonized by D-type cyclins through a cyclin-dependent-kinase-independent mechanism Mol Cell Biol 18 1998 1590 1600
22. A. Mallakin, T. Sugiyama, F. Kai, P. Taneja, R.D. Kendig, D.P. Frazier, D. Maglic, L.A. Matise, M.C. Willingham, and K. Inoue The Arf-inducing transcription factor Dmp1 encodes a transcriptional activator of amphiregulin, thrombospondin-1, JunB and Egr1 Int J Cancer 126 2010 1403 1416
23. P. Taneja, A. Mallakin, L.A. Matise, D.P. Frazier, M. Choudhary, and K. Inoue Repression of Dmp1 and Arf transcription by anthracyclins: critical roles of the NF-kappa B subunit p65 Oncogene 26 2007 7457 7466
24. A. Mallakin, P. Taneja, L.A. Matise, M.C. Willingham, and K. Inoue Expression of Dmp1 in specific differentiated, nonproliferating cells and its regulation by E2Fs Oncogene 25 2006 7703 7713
25. H. Hirai, and C.J. Sherr Interaction of D-type cyclins with a novel myb-like transcription factor, DMP1 Mol Cell Biol 16 1996 6457 6467
26. T.C. Wang, R.D. Cardiff, L. Zukerberg, E. Lees, A. Arnold, and E.V. Schmidt Mammary hyperplasia and carcinoma in MMTV-cyclin D1 transgenic mice Nature 369 1994 669 671
27. D.I. Lin, M.D. Lessie, A.B. Gladden, C.H. Bassing, K.U. Wagner, and J.A. Diehl Disruption of cyclin D1 nuclear export and proteolysis accelerates mammary carcinogenesis Oncogene 27 2008 1231 1242
28. C.J. Sherr The INK4a/ARF network in tumour suppression Nat Rev Mol Cell Biol 2 2001 731 737
29. E.K. Han, S.C. Ng, N. Arber, M. Begemann, and I.B. Weinstein Roles of cyclin D1 and related genes in growth inhibition, senescence and apoptosis Apoptosis 4 1999 213 219
30. R.J. Lee, C. Albanese, M.F. Fu, M. D'Amico, B. Lin, G. Watanabe, G.K. Haines, P.M. Siegel, M.C. Hung, Y. Yarden, J.M. Horowitz, W.J. Muller, and R.G. Pestell Cyclin D1 is required for transformation by activated Neu and is induced through an E2F-dependent signaling pathway Mol Cell Biol 20 2000 672 683
31. K. Inoue, A. Mallakin, and D.P. Frazier Dmp1 and tumor suppression Oncogene 26 2007 4329 4335
32. N. Ohtani, Z. Zebedee, T.J. Huot, J.A. Stinson, M. Sugimoto, Y. Ohashi, A.D. Sharrocks, G. Peters, and E. Hara Opposing effects of Ets and Id proteins on p16INK4a expression during cellular senescence Nature 409 2001 1067 1070
33. D.P. Frazier, R.D. Kendig, F. Kai, D. Maglic, T. Sugiyama, R.L. Morgan, E.A. Fry, S.J. Lagedrost, G. Sui, and K. Inoue Dmp1 physically interacts with p53 and positively regulates p53's stability, nuclear localization, and function Cancer Res 72 2012 1740 1750
34. M. Modestou, V. Puig-Antich, C. Korgaonkar, A. Eapen, and D.E. Quelle The alternative reading frame tumor suppressor inhibits growth through p21-dependent and p21-independent pathways Cancer Res 61 2001 3145 3150
35. A. Datta, J. Sen, J. Hagen, C.K. Korgaonkar, M. Caffrey, D.E. Quelle, D.E. Hughes, T.J. Ackerson, R.H. Costa, and P. Raychaudhuri ARF directly binds DP1: interaction with DP1 coincides with the G(1) arrest function of ARF Mol Cell Biol 25 2005 8024 8036
36. A.C. Zambon Characterization of the human Ki67 promoter for high-throughput functional genomic screens of G1-S phase cell-cycle regulation (abstract) FASEB J 22 2008 636.3
37. C.W. Yang, V. Ionescu-Tiba, K. Burns, M. Gadd, L. Zukerberg, D.N. Louis, D. Sgroi, and E.V. Schmidt The role of the cyclin D1-dependent kinases in ErbB2-mediated breast cancer Am J Pathol 164 2004 1031 1038
38. Q. Yu, Y. Geng, and P. Sicinski Specific protection against breast cancers by cyclin D1 ablation Nature 411 2001 1017 1021